You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 10, May 26, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Venous Thromboembolism
 •Cardiovascular System
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thrombolysis in the Treatment of Submassive Pulmonary Embolism

Since this article does not have an abstract, we have provided the first 134 words of the full text and any section headings.

Dr Dalen, in his editorial regarding the role of thrombolytic therapy in the treatment of pulmonary embolism (PE),1 states that thrombolysis should be considered only in patients with massive PE complicated with shock until the results of a randomized trial become available.

However, such a trial has been published,2 which recruited patients with submassive PE (defined as those with confirmed acute PE or right ventricular disfunction but preserved systemic arterial pressure) and showed that heparin plus 100 mg of alteplase, given over a period of 2 hours, prevented clinical deterioration more often than a combination of heparin and placebo, without an increasing of hemorrhagic complications. Thus, thrombolytic therapy should be considered also in selected normotensive patients with PE and right ventricular dysfunction.3

Luca Mascitelli, MD
Udine, Italy

Francesca Pezzetta, MD
Gemona del Friuli, Italy

1. Dalen JE. The uncertain role of thrombolytic therapy in the treatment of pulmonary embolism [editorial]. Arch Intern Med. 2002;162:2521-2523. FREE FULL TEXT
2. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347:1143-1150. FREE FULL TEXT
3. Goldhaber SZ. Thrombolysis for pulmonary embolism. N Engl J Med. 2002;347:1131-1132. FREE FULL TEXT

Arch Intern Med. 2003;163:1238.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Thrombolysis in the Treatment of Submassive Pulmonary Embolism—Reply
James E. Dalen
Arch Intern Med. 2003;163(10):1238.
EXTRACT | FULL TEXT  

The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism
James E. Dalen
Arch Intern Med. 2002;162(22):2521-2523.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.